Roka Bioscience Company Profile (NASDAQ:ROKA)

About Roka Bioscience

Roka Bioscience logoRoka Bioscience, Inc. is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications. The detection of foodborne pathogens is accomplished using culture-based assays, immunochemical-based assays and molecular-based assays. The Company sells its Atlas Detection Assays and related consumable supplies for use with its Atlas instruments. The Company's Atlas instrument is an automated molecular diagnostic testing and a sample-in-result-out instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single, integrated platform.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ROKA
  • CUSIP:
Key Metrics:
  • Previous Close: $4.44
  • 50 Day Moving Average: $4.59
  • 200 Day Moving Average: $3.47
  • 52-Week Range: $3.66 - $16.00
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -0.96
  • P/E Growth: 0.00
  • Market Cap: $7.84M
  • Outstanding Shares: 1,841,000
  • Beta: 1.95
Profitability:
  • Net Margins: -487.61%
  • Return on Equity: -89.22%
  • Return on Assets: -50.43%
Debt:
  • Current Ratio: 2.60%
  • Quick Ratio: 2.36%
Additional Links:
Companies Related to Roka Bioscience:

Analyst Ratings

Consensus Ratings for Roka Bioscience (NASDAQ:ROKA) (?)
Ratings Breakdown: 1 Hold Rating, 1 Buy Rating
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $5.50 (29.11% upside)

Analysts' Ratings History for Roka Bioscience (NASDAQ:ROKA)
Show:
DateFirmActionRatingPrice TargetDetails
12/12/2016Roth CapitalInitiated CoverageBuy$10.00View Rating Details
3/6/2016Leerink SwannDowngradeOutperform -> Market PerformView Rating Details
11/12/2015WedbushLower Price TargetNeutral$3.00 -> $2.00View Rating Details
(Data available from 2/25/2015 forward)

Earnings

Earnings History for Roka Bioscience (NASDAQ:ROKA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/2/2017        
11/7/2016Q316($5.39)$1.50 million$1.90 millionViewListenView Earnings Details
5/4/2016Q116($0.46)($0.47)$1.56 million$1.60 millionViewN/AView Earnings Details
3/4/2016Q415($0.48)($0.56)$1.66 millionViewN/AView Earnings Details
11/11/2015Q315($0.53)($0.49)$1.75 million$1.50 millionViewN/AView Earnings Details
8/13/2015Q215($0.51)($0.54)$1.58 million$1.50 millionViewN/AView Earnings Details
5/7/2015Q115($0.50)($0.51)$1.44 million$1.51 millionViewN/AView Earnings Details
3/26/2015Q414($0.52)($0.43)$1.44 million$1.36 millionViewN/AView Earnings Details
11/10/2014($0.49)($0.64)ViewN/AView Earnings Details
8/11/2014Q214($11.28)$1.40 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Roka Bioscience (NASDAQ:ROKA)
Current Year EPS Consensus Estimate: $-17.24 EPS
Next Year EPS Consensus Estimate: $-4.44 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.44)($0.44)($0.44)
Q2 20161($0.42)($0.42)($0.42)
Q3 20161($0.43)($0.43)($0.43)
Q4 20162($3.57)($0.43)($2.00)
Q1 20171($1.19)($1.19)($1.19)
Q2 20171($1.14)($1.14)($1.14)
Q3 20171($1.08)($1.08)($1.08)
Q4 20171($1.03)($1.03)($1.03)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Roka Bioscience (NASDAQ:ROKA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Roka Bioscience (NASDAQ:ROKA)
Insider Ownership Percentage: 28.90%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/17/2014David W J McgirrDirectorBuy50,000$3.60$180,000.00View SEC Filing  
7/22/2014Patrick J KerinsMajor ShareholderBuy383,333$12.00$4,599,996.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Roka Bioscience (NASDAQ:ROKA)
DateHeadline
finance.yahoo.com logoRoka Bioscience To Exhibit And Present At IPPE 2017 Poultry Expo (NASDAQ:ROKA)
finance.yahoo.com - January 26 at 3:59 AM
News IconRoka Bioscience announces executive changes (NASDAQ:ROKA)
www.wattagnet.com - January 23 at 7:56 PM
4-traders.com logoRoka Bioscience : announces new CEO (NASDAQ:ROKA)
www.4-traders.com - January 20 at 11:01 PM
News IconRoka Bioscience announces new CEO (NASDAQ:ROKA)
www.njbiz.com - January 19 at 1:15 AM
us.rd.yahoo.com logo4:16 pm Roka Bioscience appoints Mary Duseau as President and CEO effective today (NASDAQ:ROKA)
us.rd.yahoo.com - January 18 at 12:58 AM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibit (NASDAQ:ROKA)
biz.yahoo.com - January 17 at 7:56 PM
News IconStrong Q3 Results Nudge Barracuda Networks (CUDA) Slightly Higher (NASDAQ:ROKA)
seputarkita.info - January 10 at 10:10 PM
News IconBarracuda Networks Inc (NYSE:CUDA) reports revenue of $88.8 million (NASDAQ:ROKA)
diy-home-garden.com - January 10 at 10:10 PM
newsmaker.com.au logoAt 7.8% CAGR, Food safety testing Market to register USD 8.04 Billion, Globally by 2021 (NASDAQ:ROKA)
www.newsmaker.com.au - December 26 at 9:21 AM
News IconGlobal Food safety testing Market – Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021 (NASDAQ:ROKA)
satprnews.com - December 21 at 12:28 AM
finance.yahoo.com logoCoverage initiated on Roka Bioscience by ROTH Capital (NASDAQ:ROKA)
finance.yahoo.com - December 13 at 8:00 PM
News IconFood Safety Testing Market worth USD 8.04 Billion CAGR of 7.8% in 2021 (NASDAQ:ROKA)
qwtjlive.com - December 9 at 7:31 PM
News IconGlobal Food Safety Testing Market to Exceed USD 8.04 Billion by 2021 (NASDAQ:ROKA)
virtual-strategy.com - December 7 at 12:16 AM
sbwire.com logoGlobal Food Safety Testing Market - Biocontrol Systems Incorporated, 3M Company, Roka Bioscience, Douglas Scientific (NASDAQ:ROKA)
www.sbwire.com - November 30 at 7:47 PM
fxpips.com logoNASDAQ Sessions – Most Advanced Stocks, Nov. 22 (NASDAQ:ROKA)
www.fxpips.com - November 22 at 11:47 AM
finance.yahoo.com logoROKA BIOSCIENCE, INC. Financials (NASDAQ:ROKA)
finance.yahoo.com - November 16 at 7:31 PM
News IconThird Quarter 2016 Financial Results: (NASDAQ:ROKA)
www.biospace.com - November 8 at 7:01 PM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:ROKA)
biz.yahoo.com - November 8 at 7:01 PM
publicnow.com logoRoka Bioscience Reports Third Quarter 2016 Financial Results (NASDAQ:ROKA)
www.publicnow.com - November 7 at 8:01 PM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 8-K, Results of Operations and Financial Condition (NASDAQ:ROKA)
biz.yahoo.com - November 7 at 8:01 PM
biz.yahoo.com logoQ3 2016 Roka Bioscience Inc Earnings Release - After Market Close (NASDAQ:ROKA)
biz.yahoo.com - November 7 at 11:09 AM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 8-K, Other Events (NASDAQ:ROKA)
biz.yahoo.com - November 1 at 7:25 PM
benzinga.com logoRoka Bioscience to Report Third Quarter 2016... (NASDAQ:ROKA)
www.benzinga.com - October 31 at 6:56 PM
publicnow.com logoRoka Bioscience to Report Third Quarter 2016 Financial Results On November 7, 2016 (NASDAQ:ROKA)
www.publicnow.com - October 31 at 6:56 PM
News IconSeesawing Stock Seeing Increased Volume Today: TransAlta Corp. (NYSE:TAC) (NASDAQ:ROKA)
leglobaliste.com - October 31 at 7:17 AM
finanznachrichten.de logoLeading Subject Matter Experts Will Address Key Issues and Solutions at Food Safety Summit Resource Center at PACK EXPO (NASDAQ:ROKA)
www.finanznachrichten.de - October 27 at 7:13 PM
openpr.com logoFood Safety Testing Market will Reach Around USD 8.04 Billion in 2021 (NASDAQ:ROKA)
www.openpr.com - October 27 at 12:07 PM
publicnow.com logoRoka Bioscience to Present at the Sidoti & Company Fall 2016 Emerging Growth Convention (NASDAQ:ROKA)
www.publicnow.com - October 25 at 7:09 PM
openpr.com logoFood Safety Testing Market expected to Reach Around USD 8.04 Billion in 2021 (NASDAQ:ROKA)
www.openpr.com - October 18 at 12:26 PM
streetinsider.com logoRoka Bioscience (ROKA) to Effect 1-for-10 Reverse Stock Split (NASDAQ:ROKA)
www.streetinsider.com - October 12 at 7:02 PM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year (NASDAQ:ROKA)
biz.yahoo.com - October 11 at 7:26 PM
publicnow.com logoRoka Bioscience, Inc. Announces One-For-Ten Reverse Stock Split (NASDAQ:ROKA)
www.publicnow.com - October 11 at 7:26 PM
finance.yahoo.com logoRoka Bioscience, Inc. to present at The MicroCap Conference on October 24-25 in Philadelphia (NASDAQ:ROKA)
finance.yahoo.com - October 11 at 7:26 PM
4-traders.com logoROKA BIOSCIENCE, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities (form 8-K) (NASDAQ:ROKA)
www.4-traders.com - September 23 at 11:47 AM
publicnow.com logoRoka Bioscience, Inc. Completes Private Placement of Preferred Stock and Warrants (NASDAQ:ROKA)
www.publicnow.com - September 22 at 11:55 AM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Sec (NASDAQ:ROKA)
biz.yahoo.com - September 22 at 11:55 AM
News IconInvestor News: Deadline upcoming in Settlement of the Lawsuit against Roka Bioscience Inc (NASDAQ: ROKA) (NASDAQ:ROKA)
www.groundreport.com - September 21 at 11:08 AM
streetinsider.com logoRoka Bioscience (ROKA) Prices $22.5M Series A Preferred Stock Private Placement (NASDAQ:ROKA)
www.streetinsider.com - September 18 at 11:17 AM
4-traders.com logoROKA BIOSCIENCE, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) (NASDAQ:ROKA)
www.4-traders.com - September 18 at 11:17 AM
biz.yahoo.com logoROKA BIOSCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibi (NASDAQ:ROKA)
biz.yahoo.com - September 16 at 6:51 PM
finance.yahoo.com logo9:03 am Roka Bioscience enters into $22.5 mln private placement of approx. 22,500 shares of its Series A Preferred Stock (NASDAQ:ROKA)
finance.yahoo.com - September 16 at 10:39 AM
publicnow.com logoRoka Bioscience, Inc. Prices Private Placement of Preferred Stock and Warrants (NASDAQ:ROKA)
www.publicnow.com - September 16 at 10:39 AM
sbwire.com logoFood Safety Testing Market to Grow Steadily at 7.8% CAGR from 2014 - 2021 (NASDAQ:ROKA)
www.sbwire.com - September 7 at 7:13 PM
publicnow.com logoRoka Bioscience to Co-Present Industry Webinar - Play FDA for a day (NASDAQ:ROKA)
www.publicnow.com - September 7 at 7:13 PM
openpr.com logoFood Safety Testing Market will increase 7.8% CAGR by 2021, Says Zion Market Research (NASDAQ:ROKA)
www.openpr.com - September 6 at 7:14 PM
News IconGlobal Food Safety Testing Market expected to reach USD 8.04 Billion by 2021: Zion Market Research (NASDAQ:ROKA)
www.abnewswire.com - September 6 at 7:14 PM
News IconFood Safety Testing Market will hit USD 8.04 Billion worldwide in 2021 (NASDAQ:ROKA)
www.medgadget.com - September 6 at 7:14 PM
openpr.com logoFood Safety Testing Market will reach USD 8.04 Billion in 2021, Globally (NASDAQ:ROKA)
www.openpr.com - September 2 at 12:00 PM
4-traders.com logoCity of Providence RI : Mayor Elorza Statement Regarding LNG Facility (NASDAQ:ROKA)
www.4-traders.com - August 26 at 6:51 PM
openpr.com logoGlobal Food safety testing Market: Industry Size, Share, Trends Analysis and Forecast, 2015 – 2021 (NASDAQ:ROKA)
www.openpr.com - August 19 at 10:06 AM

Social

What is Roka Bioscience's stock symbol?

Roka Bioscience trades on the NASDAQ under the ticker symbol "ROKA."

Where is Roka Bioscience's stock going? Where will Roka Bioscience's stock price be in 2017?

2 analysts have issued twelve-month price objectives for Roka Bioscience's stock. Their predictions range from $1.00 to $10.00. On average, they expect Roka Bioscience's share price to reach $5.50 in the next year.

When will Roka Bioscience announce their earnings?

Roka Bioscience is scheduled to release their next quarterly earnings announcement on Thursday, March, 2nd 2017.

Who owns Roka Bioscience stock?

Roka Bioscience's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Orbimed Advisors LLC (48.53%), Sabby Healthcare Master Fund, Ltd (7.30%), Armistice Capital LLC (12.82%) and Birchview Capital LP (2.54%).

Who sold Roka Bioscience stock? Who is selling Roka Bioscience stock?

Roka Bioscience's stock was sold by a variety of institutional investors in the last quarter, including Orbimed Advisors LLC and Birchview Capital LP.

Who bought Roka Bioscience stock? Who is buying Roka Bioscience stock?

Roka Bioscience's stock was purchased by a variety of institutional investors in the last quarter, including Armistice Capital LLC.

How do I buy Roka Bioscience stock?

Shares of Roka Bioscience can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Roka Bioscience stock cost?

One share of Roka Bioscience stock can currently be purchased for approximately $4.26.

Roka Bioscience (NASDAQ:ROKA) Chart for Saturday, February, 25, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Roka Bioscience (NASDAQ:ROKA)

Earnings History Chart

Earnings by Quarter for Roka Bioscience (NASDAQ:ROKA)

Dividend History Chart

Dividend Payments by Quarter for Roka Bioscience (NASDAQ:ROKA)

Last Updated on 2/25/2017 by MarketBeat.com Staff